LPCN vs NVO
Lipocine Inc (LPCN) versus NVO (NVO) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
NVO (NVO) common stock.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
NVO does not have a complete income-statement cache yet.
LPCN currently screens at market cap $19.3M. NVO currently screens at market cap $0.
Not investment advice. Open the LPCN and NVO stock pages for the full models.
Not investment advice.